---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-051090"
form_type: "8-K"
ticker: "TELO"
cik: "0001971532"
company_name: "Telomir Pharmaceuticals, Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:35:16.065148+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Telomir Pharmaceuticals replaces auditor Cherry Bekaert with Salberg & Company after material weakness disclosure

## Summary
- Cherry Bekaert LLP resigned as independent auditor effective Dec 16, 2024; no disagreements on accounting principles.
- Auditor previously identified material weaknesses in internal control over financial reporting as of Dec 31, 2023 and 2022.
- Company engaged Salberg & Company P.A. as new independent registered public accountant on Dec 18, 2024.
- Prior audit reports (2022, 2023) were unqualified except for a going concern explanatory paragraph.

## SEC filing metadata
- accession: 0001493152-24-051090
- form_type: 8-K
- ticker: TELO
- cik: 0001971532
- company_name: Telomir Pharmaceuticals, Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971532/000149315224051090/0001493152-24-051090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971532/000149315224051090/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-051090
- JSON: https://secwatch.observer/filing/0001493152-24-051090.json
- Plain text: https://secwatch.observer/filing/0001493152-24-051090.txt

## Key facts
- Auditor Changes
  Telomir Pharmaceuticals, Inc. engaged Salberg & Company P.A. as its auditor.
  - Action: engagement
  - Auditor: Salberg & Company P.A.
  source text: On December 18 th , 2024, the Company engaged Salberg & Company P.A. (“Salberg”) as its new independent registered public accountant for the fiscal year ending December 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1971532/000149315224051090/0001493152-24-051090-index.htm
- Auditor Changes
  Cherry Bekaert LLP resigned as auditor of Telomir Pharmaceuticals, Inc..
  - Action: resignation
  - Auditor: Cherry Bekaert LLP
  source text: By letter dated December 16, 2024, Cherry Bekaert LLP (“Cherry Bekaert”) notified the Audit Committee of the Board of Directors (the “Audit Committee”) of Telomir Pharmaceuticals, Inc’s (the “Company”) of its resignation as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1971532/000149315224051090/0001493152-24-051090-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.